BSE filing, NSE: MINFY. Summary written from the filing by ALFA Finder's alert engine.
Mahaveer Infoway Ltd: key numbers
- Share price
- ₹10.00
- Market cap
- ₹5.51 Cr
- Revenue (annual)
- ₹2.61 Cr
- Net profit (annual)
- ₹0.64 Cr
- P/E (TTM)
- 13.5×Sector 22.9×
- Promoter holding
- 47.07%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahaveer Infoway Ltd
All →Mahaveer Infoway Other Announcement
Mahaveer Infoway Ltd has filed its quarterly shareholding pattern for the quarter ended September 30, 2026.
Mahaveer Infoway Management Change
Mahaveer Infoway Limited has appointed Ms. Sanjana Soni as Company Secretary, effective September 30, 2026.
Mahaveer Infoway Annual General Meeting
Mahaveer Infoway Limited held its 35th Annual General Meeting on September 30, 2026. Shareholders approved the audited financial statements and the reappointment of Director Ashok Kumar Jain.
Mahaveer Infoway Annual Report
Mahaveer Infoway Ltd filed its 35th Annual Report for FY 2025-26 under Reg 34. The report covers business activities, financials and the AGM notice.
Mahaveer Infoway Annual General Meeting
Mahaveer Infoway Ltd has submitted the notice for its 35th Annual General Meeting and the Annual Report for the financial year 2025-26.
Mahaveer Infoway Board Meeting Outcome
The Board approved the 35th AGM notice, appointed a new director, and authorized proposals for loans and guarantees for shareholder approval.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.